• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于生物学和治疗应用的基于发夹结构的RNAi载体的构建。

Generation of hairpin-based RNAi vectors for biological and therapeutic application.

作者信息

Boudreau Ryan L, Davidson Beverly L

机构信息

Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.

出版信息

Methods Enzymol. 2012;507:275-96. doi: 10.1016/B978-0-12-386509-0.00014-4.

DOI:10.1016/B978-0-12-386509-0.00014-4
PMID:22365779
Abstract

RNA interference (RNAi) is a natural process of gene silencing mediated by small RNAs. Shortly after the discovery of the RNAi mechanism, scientists devised various methods of delivering small interfering RNAs (siRNAs) capable of co-opting the endogenous RNAi machinery and suppressing target gene expression based on sequence complementarity. RNAi has since become a powerful tool to study gene function and is being investigated as a potential therapeutic approach to treat a vast array of human diseases (e.g., cancer, viral infections, and dominant genetic disorders). Among the available RNAi vectors are hairpin-based expression platforms (short-hairpin RNAs and artificial microRNAs) designed to mimic endogenously expressed inhibitory RNAs. These RNAi vectors are capable of achieving long-term potent gene silencing in vitro and in vivo. Here, we describe methods to design and generate these hairpin-based vectors and briefly review considerations for downstream applications.

摘要

RNA干扰(RNAi)是由小RNA介导的一种天然基因沉默过程。在RNAi机制被发现后不久,科学家们就设计出了各种递送小干扰RNA(siRNA)的方法,这些小干扰RNA能够借助内源性RNAi机制,基于序列互补性来抑制靶基因表达。自那以后,RNAi已成为研究基因功能的强大工具,并且正在作为一种潜在的治疗方法来研究,用于治疗一系列人类疾病(如癌症、病毒感染和显性遗传病)。现有的RNAi载体中,有基于发夹结构的表达平台(短发夹RNA和人工微小RNA),其设计目的是模拟内源性表达的抑制性RNA。这些RNAi载体能够在体外和体内实现长期有效的基因沉默。在此,我们描述了设计和生成这些基于发夹结构载体的方法,并简要回顾了下游应用的注意事项。

相似文献

1
Generation of hairpin-based RNAi vectors for biological and therapeutic application.用于生物学和治疗应用的基于发夹结构的RNAi载体的构建。
Methods Enzymol. 2012;507:275-96. doi: 10.1016/B978-0-12-386509-0.00014-4.
2
Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.人泡沫病毒载体表达的小干扰RNA对乙型肝炎病毒复制的有效抑制作用
Int J Mol Med. 2007 Apr;19(4):705-11.
3
Vectors and methods for hairpin RNA and artificial microRNA-mediated gene silencing in plants.用于植物中发夹RNA和人工微小RNA介导的基因沉默的载体和方法。
Methods Mol Biol. 2011;701:179-97. doi: 10.1007/978-1-61737-957-4_10.
4
pSM155 and pSM30 vectors for miRNA and shRNA expression.用于miRNA和shRNA表达的pSM155和pSM30载体。
Methods Mol Biol. 2009;487:205-19. doi: 10.1007/978-1-60327-547-7_10.
5
Transkingdom RNA interference (tkRNAi) as a new delivery tool for therapeutic RNA.跨物种 RNA 干扰 (tkRNAi) 作为治疗性 RNA 的新型递送工具。
Expert Opin Biol Ther. 2009 Dec;9(12):1533-42. doi: 10.1517/14712590903307354.
6
[RNA interference: from origins to a novel tool for gene silencing].[RNA干扰:从起源到基因沉默的新型工具]
Rev Invest Clin. 2009 Sep-Oct;61(5):412-27.
7
Viral vector-mediated RNA interference.病毒载体介导的 RNA 干扰。
Curr Opin Pharmacol. 2010 Oct;10(5):534-42. doi: 10.1016/j.coph.2010.06.007. Epub 2010 Jul 9.
8
Design of expression vectors for RNA interference based on miRNAs and RNA splicing.基于微小RNA和RNA剪接的RNA干扰表达载体设计
FEBS J. 2006 Dec;273(23):5421-7. doi: 10.1111/j.1742-4658.2006.05534.x. Epub 2006 Oct 31.
9
RNAi-inducing lentiviral vectors for anti-HIV-1 gene therapy.用于抗HIV-1基因治疗的RNA干扰诱导慢病毒载体
Methods Mol Biol. 2011;721:293-311. doi: 10.1007/978-1-61779-037-9_18.
10
Delivery of RNA interference to peripheral neurons in vivo using herpes simplex virus.利用单纯疱疹病毒在体内将RNA干扰传递至外周神经元。
Methods Mol Biol. 2010;617:347-61. doi: 10.1007/978-1-60327-323-7_26.

引用本文的文献

1
Role of c-ABL in DENV-2 Infection and Actin Remodeling in Vero Cells.c-ABL在登革热病毒2型(DENV-2)感染及Vero细胞肌动蛋白重塑中的作用
Int J Mol Sci. 2025 Apr 29;26(9):4206. doi: 10.3390/ijms26094206.
2
α-Adrenergic receptor-PKC-Pyk2-Src signaling boosts L-type Ca channel Ca1.2 activity and long-term potentiation in rodents.α-肾上腺素能受体-PKC-Pyk2-Src 信号通路增强了啮齿动物的 L 型钙通道 Ca1.2 活性和长时程增强。
Elife. 2023 Jun 20;12:e79648. doi: 10.7554/eLife.79648.
3
Fibroblast growth factor homologous factor 2 attenuates excitability of DRG neurons.
成纤维细胞生长因子同源因子 2 可降低背根神经节神经元的兴奋性。
J Neurophysiol. 2022 Nov 1;128(5):1258-1266. doi: 10.1152/jn.00361.2022. Epub 2022 Oct 12.
4
Human miRNA miR-675 inhibits DUX4 expression and may be exploited as a potential treatment for Facioscapulohumeral muscular dystrophy.人类 miRNA miR-675 可抑制 DUX4 的表达,或可作为治疗面肩肱型肌营养不良症的潜在方法。
Nat Commun. 2021 Dec 8;12(1):7128. doi: 10.1038/s41467-021-27430-1.
5
Fibroblast growth factor homologous factor 2 (FGF-13) associates with Nav1.7 in DRG neurons and alters its current properties in an isoform-dependent manner.成纤维细胞生长因子同源因子2(FGF - 13)与背根神经节(DRG)神经元中的Nav1.7相关联,并以一种异构体依赖的方式改变其电流特性。
Neurobiol Pain. 2019 Mar 27;6:100029. doi: 10.1016/j.ynpai.2019.100029. eCollection 2019 Aug-Dec.
6
Oligonucleotide therapeutics in neurodegenerative diseases.神经退行性疾病的寡核苷酸治疗。
RNA Biol. 2018;15(6):707-714. doi: 10.1080/15476286.2018.1454812. Epub 2018 Jun 1.
7
Retroviral Replicating Vector Delivery of miR-PDL1 Inhibits Immune Checkpoint PDL1 and Enhances Immune Responses In Vitro.miR-PDL1的逆转录病毒复制载体递送可抑制免疫检查点PDL1并增强体外免疫反应。
Mol Ther Nucleic Acids. 2017 Mar 17;6:221-232. doi: 10.1016/j.omtn.2016.11.007. Epub 2016 Dec 10.
8
RNA Interference of Human α-Synuclein in Mouse.小鼠中人类α-突触核蛋白的RNA干扰
Front Neurol. 2017 Jan 31;8:13. doi: 10.3389/fneur.2017.00013. eCollection 2017.
9
RNA Interference Prevents Autosomal-Dominant Hearing Loss.RNA干扰可预防常染色体显性遗传性听力损失。
Am J Hum Genet. 2016 Jun 2;98(6):1101-1113. doi: 10.1016/j.ajhg.2016.03.028. Epub 2016 May 26.
10
Sonic Hedgehog Controls the Phenotypic Fate and Therapeutic Efficacy of Grafted Neural Precursor Cells in a Model of Nigrostriatal Neurodegeneration.音猬因子在黑质纹状体神经退行性变模型中控制移植神经前体细胞的表型命运和治疗效果。
PLoS One. 2015 Sep 4;10(9):e0137136. doi: 10.1371/journal.pone.0137136. eCollection 2015.